Literature DB >> 22036649

Chemokines in tumor development and progression.

Naofumi Mukaida1, Tomohisa Baba.   

Abstract

Chemokines were originally identified as mediators of the inflammatory process and regulators of leukocyte trafficking. Subsequent studies revealed their essential roles in leukocyte physiology and pathology. Moreover, chemokines have profound effects on other types of cells associated with the inflammatory response, such as endothelial cells and fibroblasts. Thus, chemokines are crucial for cancer-related inflammation, which can promote tumor development and progression. Increasing evidence points to the vital effects of several chemokines on the proliferative and invasive properties of tumor cells. The wide range of activities of chemokines in tumorigenesis highlights their roles in tumor development and progression.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22036649     DOI: 10.1016/j.yexcr.2011.10.012

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  40 in total

1.  Analysis of the prognostic role of an immune checkpoint score in resected non-small cell lung cancer patients.

Authors:  Marta Usó; Eloísa Jantus-Lewintre; Silvia Calabuig-Fariñas; Ana Blasco; Eva García Del Olmo; Ricardo Guijarro; Miguel Martorell; Carlos Camps; Rafael Sirera
Journal:  Oncoimmunology       Date:  2016-12-07       Impact factor: 8.110

Review 2.  Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?

Authors:  Nayoung Lee; Steven R Barthel; Tobias Schatton
Journal:  Lab Invest       Date:  2013-10-14       Impact factor: 5.662

3.  Alternative C-terminal helix orientation alters chemokine function: structure of the anti-angiogenic chemokine, CXCL4L1.

Authors:  Je-Hung Kuo; Ya-Ping Chen; Jai-Shin Liu; Alexandre Dubrac; Cathy Quemener; Hervé Prats; Andreas Bikfalvi; Wen-guey Wu; Shih-Che Sue
Journal:  J Biol Chem       Date:  2013-03-27       Impact factor: 5.157

4.  CCL21/CCR7 axis activating chemotaxis accompanied with epithelial-mesenchymal transition in human breast carcinoma.

Authors:  Fei Li; Zhigeng Zou; Ning Suo; Zongpu Zhang; Fangzhu Wan; Guangxin Zhong; Yan Qu; Kwanele Siphelele Ntaka; Hua Tian
Journal:  Med Oncol       Date:  2014-08-21       Impact factor: 3.064

Review 5.  Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy.

Authors:  Weiqiang Zhou; Shanchun Guo; Mingli Liu; Matthew E Burow; Guangdi Wang
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

6.  F-box protein FBXW7 inhibits cancer metastasis in a non-cell-autonomous manner.

Authors:  Kanae Yumimoto; Sayuri Akiyoshi; Hiroki Ueo; Yasuaki Sagara; Ichiro Onoyama; Hiroaki Ueo; Shinji Ohno; Masaki Mori; Koshi Mimori; Keiichi I Nakayama
Journal:  J Clin Invest       Date:  2015-01-02       Impact factor: 14.808

7.  Treatment with the C-C chemokine receptor type 5 (CCR5)-inhibitor maraviroc suppresses growth and induces apoptosis of acute lymphoblastic leukemia cells.

Authors:  Jie Zi; Shushu Yuan; Jianlin Qiao; Kai Zhao; Linyan Xu; Kunming Qi; Kailin Xu; Lingyu Zeng
Journal:  Am J Cancer Res       Date:  2017-04-01       Impact factor: 6.166

8.  Differential gene expression of chemokines in KRAS and BRAF mutated colorectal cell lines: role of cytokines.

Authors:  Sajjad Khan; Silke Cameron; Martina Blaschke; Federico Moriconi; Naila Naz; Ahmad Amanzada; Giuliano Ramadori; Ihtzaz Ahmed Malik
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

9.  TNF-α increases the membrane expression of the chemokine receptor CCR6 in thyroid tumor cells, but not in normal thyrocytes: potential role in the metastatic spread of thyroid cancer.

Authors:  Francesca Coperchini; Patrizia Pignatti; Andrea Carbone; Rossana Bongianino; Christian A Di Buduo; Paola Leporati; Laura Croce; Flavia Magri; Alessandra Balduini; Luca Chiovato; Mario Rotondi
Journal:  Tumour Biol       Date:  2015-11-17

Review 10.  Fibroblasts, an inconspicuous but essential player in colon cancer development and progression.

Authors:  Naofumi Mukaida; Soichiro Sasaki
Journal:  World J Gastroenterol       Date:  2016-06-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.